Of the 25 relapsed patients with good concordance between IDH1/2 LNA-qPCR MRD and diagnosis-remission status, all patients retained IDH1/2 mutation at relapse, and the stability of IDH1/2 LNA-qPCR at AML relapse was 100% (25/25). Here, IDH1 is linked to acute myeloid leukemia.